Inhixa Multi 30000 IE (300 mg)
Inhixa Multi 30000 IE (300 mg) is a medicine authorised by Swissmedic under authorisation number 67455. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 June 2020 and the authorisation is valid without a time limit. ATC code B01AB05 places the medicine in the group Antithrombotic agents.
| Authorisation number | 67455 |
|---|---|
| Name | Inhixa Multi 30000 IE (300 mg) |
| Full name | Inhixa Multi 30000 IE (300 mg), Injektionslösung |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AB05 |
| First authorisation | 10 June 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Inhixa Multi 30000 IE (300 mg), Injektionslösung | B | 10 June 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | B01AB05 | 06.03.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Inhixa Multi 30000 IE (300 mg) authorised in Switzerland?
Yes. Inhixa Multi 30000 IE (300 mg) is authorised by Swissmedic under authorisation number 67455, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Inhixa Multi 30000 IE (300 mg) have?
Inhixa Multi 30000 IE (300 mg) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Inhixa Multi 30000 IE (300 mg)?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.